awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38218209-0CFB7AF1-CB6F-455C-BADC-CB7DF6DD80B5
Q38218209-0CFB7AF1-CB6F-455C-BADC-CB7DF6DD80B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218209-0CFB7AF1-CB6F-455C-BADC-CB7DF6DD80B5
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma.
P2860
Q38218209-0CFB7AF1-CB6F-455C-BADC-CB7DF6DD80B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218209-0CFB7AF1-CB6F-455C-BADC-CB7DF6DD80B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f9aef7cab8ed96072732137788f6a690703936f
P2860
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).